News & Perspective

Jul 11, 2014

Jul 11, 2014
BSL-4 lab worker

More problems shutter CDC labs, prompt review

In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.

May 12, 2011

May 12, 2011

NRC seeks changes in US vaccine program for biodefense workers

(CIDRAP News) – A report from the National Research Council (NRC) calls for some changes in a US Army immunization program for lab researchers who work with dangerous pathogens, saying the vaccines need to be made more accessible to civilian scientists.

Apr 21, 2011

Apr 21, 2011

FDA strategic plan promises new food safety approaches

(CIDRAP News) – A 5-year strategic plan released yesterday by the US Food and Drug Administration (FDA) promises new approaches to food safety in line with new legislation and increased efforts to smooth the regulatory pathway for medical defenses against biological and other unconventional attacks.

Feb 12, 2010

Feb 12, 2010

Report: For biodefense, US needs closer ties to industry

(CIDRAP News) – The US government needs much closer collaboration with private industry—like the arrangements used in building aircraft carriers and putting men on the moon—in order to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats, says a report from a federal advisory panel.

Mar 07, 2008

Mar 07, 2008

CDC retires one old smallpox vaccine, keeps another

(CIDRAP News) – Federal health officials recently announced plans to get rid of their last remaining stocks of the decades-old smallpox vaccine Dryvax, as a newer vaccine takes its place in the national stockpile of emergency medical supplies.

Dec 20, 2006

Dec 20, 2006

HHS cancels VaxGen anthrax vaccine contract

(CIDRAP News) – The US government yesterday canceled its $877.5 million contract with VaxGen Inc. for a new anthrax vaccine, after problems with the vaccine's stability caused the company to miss a deadline for starting a clinical trial.

Jul 21, 2004

Jul 21, 2004

Bush signs BioShield legislation

(CIDRAP News) – President Bush today signed the bill establishing Project BioShield, a $5.6 billion program to speed the development of drugs and vaccines to combat the effects of biological, chemical, nuclear, and radiological agents.

May 20, 2004

May 20, 2004

Senate passes 'Bioshield' bill

(CIDRAP News) – The US Senate yesterday overwhelmingly passed "Project BioShield," a 10-year, $5.6 billion program to promote rapid development and use of drugs and vaccines to counter biological and chemical weapons.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»